Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes.
Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM, Schaefer JB, Zarghami M, Day HL, Landin-Olsson M, Palmer JP, Janer-Villanueva M, Hood L, Sundkvist G, Lernmark A, Breslow N, Dahlquist G, Blohmé G; Diabetes Incidence in Sweden Study Group; Swedish Childhood Diabetes Study Group. Graham J, et al. Among authors: zarghami m. Diabetes. 2002 May;51(5):1346-55. doi: 10.2337/diabetes.51.5.1346. Diabetes. 2002. PMID: 11978629
D6S265*15 marks a DRB1*15, DQB1*0602 haplotype associated with attenuated protection from type 1 diabetes mellitus.
Valdes AM, Thomson G, Graham J, Zarghami M, McNeney B, Kockum I, Smith A, Lathrop M, Steenkiste AR, Dorman JS, Noble JA, Hansen JA, Pugliese A, Lernmark A; Swedish Childhood Study Group; Diabetes Incidence in Sweden Study Group; Type 1 Diabetes Component of the 13th International Histocompatibility Working Group. Valdes AM, et al. Among authors: zarghami m. Diabetologia. 2005 Dec;48(12):2540-3. doi: 10.1007/s00125-005-0011-8. Epub 2005 Nov 18. Diabetologia. 2005. PMID: 16320082
Efficacy and safety of adding fluoxetine to the treatment regimen of hospitalized patients with non-critical COVID-19 pneumonia: A double-blind randomized, placebo-controlled clinical trial.
Sedighi F, Zarghami M, Alizadeh Arimi F, Moosazadeh M, Ala S, Ghasemian R, Mehravaran H, Elyasi F. Sedighi F, et al. Among authors: zarghami m. Neuropsychopharmacol Rep. 2023 Jun;43(2):202-212. doi: 10.1002/npr2.12327. Epub 2023 Mar 20. Neuropsychopharmacol Rep. 2023. PMID: 36941089 Free PMC article. Clinical Trial.
91 results